Lorenzo Rocchini
Overview
Explore the profile of Lorenzo Rocchini including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
28
Citations
288
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Albo G, Gallioli A, Ripa F, De Lorenzis E, Boeri L, Bebi C, et al.
BMC Urol
. 2024 Apr;
24(1):86.
PMID: 38622657
No abstract available.
2.
Albo G, Gallioli A, Ripa F, De Lorenzis E, Boeri L, Bebi C, et al.
BMC Urol
. 2024 Mar;
24(1):64.
PMID: 38515053
Background: Robot-assisted radical prostatectomy (RARP) with extended lymphadenectomy (ePLND) is the gold standard for surgical treatment of prostate cancer (PCa). Recently, the en-bloc ePLND has been proposed but no studies...
3.
Bebi C, Fulgheri I, Spinelli M, Turetti M, Lievore E, Ripa F, et al.
J Endourol
. 2021 Oct;
36(3):360-368.
PMID: 34693753
Well-defined clinical predictors of sepsis after upper tract drainage for obstructive uropathy are lacking. The study aim is to develop a data-driven score to predict risk of sepsis after decompression...
4.
Lievore E, Zanetti S, Fulgheri I, Turetti M, Silvani C, Bebi C, et al.
World J Urol
. 2021 Aug;
40(1):201-211.
PMID: 34432135
Purpose: To perform a cost analysis between vacuum-assisted percutaneous nephrolithotomy (vmPCNL) and minimally invasive PCNL (MIP) and explore potential predictors of costs associated with the procedures. Methods: We analyzed data...
5.
Bebi C, Turetti M, Lievore E, Ripa F, Rocchini L, Spinelli M, et al.
PLoS One
. 2021 Jun;
16(6):e0253083.
PMID: 34106986
Background: Bipolar Transurethral Enucleation of the Prostate (B-TUEP) is recommended as a first-choice treatment for benign prostatic obstruction in prostates >80 ml. Differently, B-TUEP is only considered as an alternative...
6.
Maccagnano C, Rocchini L, Montanari E, Conti G, Petralia G, Deho F, et al.
Arch Ital Urol Androl
. 2020 Dec;
92(4).
PMID: 33348951
Objective: Overview of bladder cancer (BC) management in Italy during the first month of the COVID-19 pandemic (March 2020) with head to head comparison of the data from March 2019,...
7.
Ripa F, Rocchini L, Boeri L, Montanari E
Urol Case Rep
. 2020 Oct;
33:101420.
PMID: 33102117
Angiomyolipoma (AML) is a benign renal mesenchymal tumor. Active surveillance is considered the most appropriate option for most AMLs. The major complication of AML is its spontaneous bleeding in the...
8.
Bebi C, Turetti M, Lievore E, Ripa F, Bilato M, Rocchini L, et al.
Int J Impot Res
. 2020 Oct;
34(1):71-80.
PMID: 33082545
Currently available surgical treatments for Lower Urinary Tract Symptoms (LUTS) due to Benign Prostatic Obstruction (BPO) are associated with an increased risk of sexual dysfunction. The aim of our study...
9.
Mangioni D, Rocchini L, Bandera A, Montanari E
J Urol
. 2020 Feb;
203(6):1214-1215.
PMID: 32003615
No abstract available.
10.
Colombo R, Rocchini L, Suardi N, Benigni F, Colciago G, Bettiga A, et al.
Eur Urol
. 2018 Nov;
75(3):e81.
PMID: 30409675
No abstract available.